MyFinsight
Home
Blog
About
Contact
kalv: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$8,488K
Research and development
tax credit...
$1,343K
Inventory
$458K
Accounts receivable, net
$5,779K
Marketable securities
$65,661K
Cash and cash
equivalents
$243,497K
Other assets
$2,419K
Right of use assets
$9,096K
Property and equipment,
net
$3,190K
Total current assets
$325,226K
Total assets
$339,931K
Total liabilities and
stockholders equity
$339,931K
Total stockholders
equity
$16,999K
Total liabilities
$322,932K
Accumulated other
comprehensive loss
-$6,729K
Accumulated deficit
-$739,098K
Additional paid-in capital
$762,776K
Convertible notes
$139,028K
Royalty obligation - net
of current portion
$129,707K
Lease liability - net
of current portion
$9,128K
Total current
liabilities
$45,069K
Common stock, 0.001 par
value 100,000,000...
$50K
Royalty obligation -
current portion
$3,287K
Lease liability -
current portion
$1,429K
Deferred revenue
$11,512K
Accrued expenses
$20,767K
Accounts payable
$8,074K
Back
Back
Balance Sheet
source: myfinsight.com
KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV)